Segment Information (Tables)

12 Months Ended

Jun. 30, 2013

Financial Information Relating to Operating Segments

Following is financial information relating to the operating segments (in thousands):

	Year Ended June 30,
	2013			2012			2011
External sales
Biotechnology	$	288,156		$	293,274		$	270,287
Clinical Controls		22,419			21,286			19,675
Consolidated net sales	$	310,575		$	314,560		$	289,962
Earnings before taxes
Biotechnology	$	156,910		$	162,763		$	164,332
Clinical Controls		8,746			8,002			7,222
Segment earnings before taxes		165,656			170,765			171,554
Other		(4,994	)		(8,570	)		(6,573	)
Consolidated earnings before taxes	$	160,662		$	162,195		$	164,981
Goodwill
Biotechnology	$	84,336		$	85,682		$	86,633
Clinical Controls		0			0			0
Consolidated goodwill	$	84,336		$	85,682		$	86,633
Intangible assets, net
Biotechnology	$	40,552		$	46,476		$	52,282
Clinical Controls		0			0			0
Consolidated intangible assets, net	$	40,552		$	46,476		$	52,282
Assets
Biotechnology	$	580,085		$	529,392		$	505,087
Clinical Controls		24,887			22,135			21,046
Segment assets		604,972			551,527			526,133
Other		173,126			167,797			91,537
Consolidated assets	$	778,098		$	719,324		$	617,670
Depreciation and amortization
Biotechnology	$	10,781		$	10,920		$	7,165
Clinical Controls		389			411			417
Segment depreciation and amortization		11,170			11,331			7,582
Other		1,151			1,136			1,118
Consolidated depreciation and amortization	$	12,321		$	12,467		$	8,700
Capital purchases
Biotechnology	$	3,248		$	4,021		$	2,707
Clinical Controls		6,914			597			149
Segment capital purchases		10,162			4,618			2,856
Other		12,292			1,399			774
Consolidated capital purchases	$	22,454		$	6,017		$	3,630

Financial Information Relating to Geographic Areas

Following is financial information relating to geographic areas (in thousands):

	Year Ended June 30,
	2013		2012		2011
External sales
United States	$	164,308	$	172,310	$	159,857
Europe		88,297		90,142		83,676
China		14,106		11,378		8,299
Other Asia		28,608		25,988		24,715
Rest of world		15,256		14,742		13,415
Total external sales	$	310,575	$	314,560	$	289,962
Long-lived assets
United States	$	103,541	$	87,968	$	88,802
Europe		7,129		7,528		7,819
China		117		141		96
Total long-lived assets	$	110,787	$	95,637	$	96,717